West Pharmaceutical Services | WST - Gewinn Vor Steuern





Gewinn Vor Steuern Veränderung Datum
Align Technology USD 148.89M 27.71M 2026-03
Avanos Medical USD 1.2M 2.4M 2025-12
Baxter International USD -756M 877M 2025-12
Becton, Dickinson and Co. USD 393M 117M 2025-12
Cerus USD -20.76M 17.9M 2024-12
Charles River Laboratories USD -294.1M 464.13M 2025-12
Cooper Companies USD 192.2M 75.4M 2025-12
Dentsply International USD -42M 105M 2026-03
Haemonetics USD 59.97M 8.69M 2025-12
ICU Medical USD -15.9M 86.2M 2025-12
Insulet USD 113M 27.2M 2026-03
Integra LifeSciences USD -2.41M 6.72M 2026-03
IQVIA Holdings USD 6.22B 5.68B 2026-03
J&J USD 7.82B 2.86B 2026-03
Medtronic USD 2.45B 1.04B 2026-03
Merit Medical Systems USD 51.06M 22.12M 2025-12
Neogen USD 28M 15.81M 2025-09
OraSure Technologies USD -18.43M 5.14M 2025-12
Quidel USD -79.5M 32.9M 2026-03
Repligen USD 19.11M 2M 2025-12
Rockwell Medical USD 343K 2.07M 2024-06
Solventum Corp USD 332M 179M 2025-12
STAAR Surgical USD -20.65M 39.44M 2025-12
Terumo JPY 31.67B 13.71B 2026-03
Utah Medical Products 418K 3K 2024-09
West Pharmaceutical Services USD 161.5M 8.6M 2025-12